# A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

> clinical trial · VERIFIED · 2026-08-03

Status: RECRUITING · Sponsor: Zenas BioPharma (USA), LLC · Condition: Secondary Progressive Multiple Sclerosis

- Company: Zenas BioPharma (USA), LLC
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT07299019

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.